statistiche ricercatore

CAMPOMENOSI, PAOLA

Distribuzione geografica

Continente	#
NA - Nord America	4.830
EU - Europa	3.357
AS - Asia	819
SA - Sud America	15
Continente sconosciuto - Info sul continente non disponibili	11
AF - Africa	2
OC - Oceania	2
Totale	9.036

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	4.739
IT - Italia	1.803
UA - Ucraina	521
TR - Turchia	319
SE - Svezia	268
DE - Germania	251
VN - Vietnam	217
CN - Cina	155
FI - Finlandia	142
IE - Irlanda	140
CA - Canada	91
SG - Singapore	89
GB - Regno Unito	80
RU - Federazione Russa	47
FR - Francia	44
BE - Belgio	18
IN - India	16
BR - Brasile	12
CZ - Repubblica Ceca	10
EU - Europa	10
JP - Giappone	7
NL - Olanda	7
ES - Italia	6
IQ - Iraq	5
RO - Romania	5
HK - Hong Kong	3
AT - Austria	2
AU - Australia	2
CL - Cile	2
DK - Danimarca	2
HU - Ungheria	2
KE - Kenya	2
LU - Lussemburgo	2
A2 - ???statistics.table.value.countryCode.A2???	1
AR - Argentina	1
AZ - Azerbaigian	1
CH - Svizzera	1
GE - Georgia	1
GR - Grecia	1
HR - Croazia	1
IR - Iran	1
KG - Kirghizistan	1
LK - Sri Lanka	1
LT - Lituania	1
MY - Malesia	1
NO - Norvegia	1
PL - Polonia	1
RS - Serbia	1
TW - Taiwan	1
UZ - Uzbekistan	1
Totale	9.036

Salva come PNG Salva come JPEG

Città	#
Milan	1.141
Fairfield	612
Chandler	460
Jacksonville	425
Woodbridge	394
Ashburn	324
Houston	269
Ann Arbor	258
Seattle	252
Wilmington	244
Cambridge	192
Como	173
Princeton	153
Nyköping	149
Dublin	140
Izmir	138
Dearborn	131
Boardman	123
Dong Ket	111
Toronto	86
Singapore	79
New York	76
Rome	66
Kocaeli	61
Beijing	53
San Diego	50
Ponte Lambro	47
San Mateo	40
Ogden	34
Chicago	26
Düsseldorf	23
Falls Church	21
Gallarate	19
Brussels	17
Santa Clara	17
London	16
Nanjing	16
Moscow	15
Los Angeles	14
Washington	14
Guangzhou	13
Munich	13
Dallas	11
Frankfurt am Main	11
Helsinki	11
Hefei	10
Redwood City	10
Verona	9
Busto Arsizio	8
Norwalk	8
Redmond	8
Varese	8
Auburn Hills	7
Berlin	7
Jinan	7
Chennai	6
Paderno Dugnano	6
Tokyo	6
Brno	5
Espoo	5
Nanchang	5
Olomouc	5
Casnate Con Bernate	4
Edinburgh	4
Granada	4
Grenoble	4
Hillah	4
Kunming	4
Langenfeld	4
Legnano	4
Prescot	4
Pune	4
Rozzano	4
São Paulo	4
Tappahannock	4
Timisoara	4
Vancouver	4
Amsterdam	3
Casorezzo	3
Chiswick	3
Garbagnate Milanese	3
Hong Kong	3
Kilburn	3
Mentana	3
Monza	3
Nashik	3
Phoenix	3
Abbiategrasso	2
Baotou	2
Brugherio	2
Budapest	2
Casatenovo	2
Changsha	2
Duncan	2
Ferrara	2
Fuzhou	2
Hebei	2
Honolulu	2
Indiana	2
Lazzate	2
Totale	6.774

Salva come PNG Salva come JPEG

Nome	#
A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer	236
Proteomic analysis of MG132-treated germinating pollen reveals expression signatures associated with proteasome inhibition	209
Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.	201
Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins	197
Effect of inulin on proteome changes induced by pathogenic lipopolysaccharide in human colon	190
The degradation (by distinct pathways) of human D-amino acid oxidase and its interacting partner pLG72--two key proteins in D-serine catabolism in the brain.	169
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.	168
TAS2R38 taste receptor gene and chronic rhinosinusitis: new data from an Italian population	160
Biochemical and immunohistochemical characterization of human RNASET2 expression	153
ΔN-p63a and ta-p63a exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites	153
Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer	149
Nucleotide excision repair defect influences lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent in the absence of base excision repair	147
Comparison of the baculovirus-insect cell and Pichia pastoris heterologous systems for the expression of the human tumor suppressor protein RNASET2	146
Analysis of 4-nitroquinoline-1-oxide induced mutations at the hprt locus in mammalian cells: possible involvement of preferential DNA repair.	145
TAS2R38 taste receptor gene and chronic rhinosinusitis: a bitter ending	145
Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line	143
Tumour p53 mutations exhibit promoter selective dominance over wild type p53	139
Lack of mutations in K-ras codons 12 and 13 in human atherosclerotic lesions.	139
Defective splicing induced by 4NQO in the hamster hprt gene.	139
P53 family members modulate the expression of PRODH, but not PRODH2, via intronic p53 response elements	139
Analysis of stepwise genetic changes in an AIDS-related Burkitt's lymphoma	137
Abstract 3402: ΔN-p63α and TA-p63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites	135
Expression of proline dehydrogenase in non-small cell lung cancer: immunohistochemical characterization and possible regulators.	134
5-methylcytosine at HpaII sites in p53 is not hypermutable after UVC irradiation.	134
TRP channels expression in Chronic Low Back Pain	130
Influences of base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence-selective N3-Adenine methylating agent	129
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements	129
Gadd45 mutations are uncommon in human tumour cell lines	127
Characterization of the p53 mutants ability to inhibit p73b transactivation using a yeast-based functional assay	124
Molecular characterization of RNASE6PL, a putative human tumor suppressor gene on chromosome 6q27.	123
Derivative chromosome 17 in a case of Burkitt lymphoma with 8;14 translocation.	123
Defective nuclear localization of p53 protein in a Chinese hamster cell line is associated with the formation of stable cytoplasmic protein multimers in cells with gene amplification.	122
Prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6	117
Heterogeneous p53 mutations in a Burkitt lymphoma from an AIDS patient with monoclonal c-myc and VDJ rearrangements.	117
p53 mutations and DNA ploidy in colorectal adenocarcinomas.	117
Protective effect of inulin on LPS-induced intestinal smooth muscle impairment: a proteomic approach.	117
The 4-nitroquinoline 1-oxide mutational spectrum in single stranded DNA is characterized by guanine to pyrimidine transversions.	110
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene	109
N-(2-chloroethyl)-N-nitrosourea tethered to lexitropsin induces minor groove lesions at the p53 cDNA that are more cytotoxic than mutagenic.	108
STUDIO FUNZIONALE DI RNASE6PL, PUTATIVO GENE ONCOSOPRESSORE LOCALIZZATO IN 6Q27	107
Caratterizzazione strutturale e funzionale di rnase6pl, un putativo gene oncosoppressore localizzato sul cromosoma 6 umano	106
Tumor and metastasis suppression by the human RNASET2 gene.	106
Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential	106
Mutation spectrum of 4-nitroquinoline 1-oxide-damaged single-stranded shuttle vector DNA transfected into monkey cells.	105
p53 mutations experimentally induced by 8-methoxypsoralen plus UVA (PUVA) differ from those found in human skin cancers in PUVA-treated patients.	104
Characterization of the p53 mutants ability to inhibit p73 beta transactivation using a yeast-based functional assay	102
Cellular and biochemical characterization of the human member of Rh/T2/S ribonucleases	101
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro	101
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites.	99
Influences of nucleotide and base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence selective N3-adenine methylating agent	97
p53 is frequently mutated in Barrett's metaplasia of the intestinal type.	96
Stable formation of mutated p53 multimers in a Chinese hamster cell line causes defective p53 nuclear localization and abrogates its residual function.	95
Amifostine (WR2721) restores transcriptional activity of speci®c p53mutant proteins in a yeast functional assay	95
Analysis of K-ras, p53, bcl-2 and Rb expression in non-small cell lung cancer cell lines.	95
The yeast p53 functional assay: a new tool for molecular epidemiology. Hopes and facts.	94
Mutational fingerprint induced by the antineoplastic drug chloroethyl-cyclohexyl-nitrosourea in mammalian cells.	89
TRPV4 and TRPM8 as putative targets for chronic low back pain alleviation	88
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression	87
Influences of nucleotide and base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence selective N3-adenine methylating agent.	87
Study of 4-NQO induced mutations at the HPRT locus in CHO cell lines. Possible influences of preferential DNA-repair on the mutational spectrum.	86
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment	84
RNASET2 is a non-cell autonomous human tumor suppressor	84
Partial characterization of SUVi, a new mammalian gene induced by UV-C and expressed during the S phase of the cell cycle	82
Measurements Methods for the Development of MicroRNA-Based Tests for Cancer Diagnosis.	82
Study on aneuploidy and p53 mutations in astrocytomas.	81
Multi-system approach to study mutagenesis induced by chemical carcinogens.	80
Human Primary Dermal Fibroblasts Interacting with 3-Dimensional Matrices for Surgical Application Show Specific Growth and Gene Expression Programs	80
Cancer biomarkers in human atherosclerotic lesions: no evidence of p53 involvement.	79
FUNCTIONAL CHARACTERIZATION OF P53 MUTANT PROTEINS: A WAY FOR UNDERSTANDING THEIR ROLE IN CARCINOGENESIS	75
Single stranded DNA-vectors for analyzing processing of DNA damage induced by 4-nitroquinoline-1-oxide in prokaryotes and eukaryotes.	75
Genetic alterations in astrocytic tumors: hints to a molecular epidemiological interpretation.	74
PROLINE DEHYDROGENASE EXPRESSION, REGULATION AND FUNCTION IN NON-SMALL CELL LUNG CARCINOMA	68
Mutation of p53 in the progression of Barrett's epithelium to invasive esophageal cancer: A prospective study	62
Beyond conventional: The new horizon of anti-angiogenic micrornas in non-small cell lung cancer therapy	59
RNASET2, a putative oncosuppressor gene: cellular and biochemical characterization	57
RNASET2 is the first ribonuclease of the Rh/T2/S family discovered in humans and displays unusual roles in tumor suppression.	55
Serum miRNAs as biomarkers for early diagnosis of non small cell lung cancer	53
Proline Dehydrogenase affects Lung Adenocarcinoma cell survival, proliferation, and 3D growth	39
Unravelling the role of proline dehydrogenase (PRODH) in lung adenocarcinoma: implications for cellular senescence and the tumor microenvironment	30
Proline Dehydrogenase (PRODH) Is Expressed in Lung Adenocarcinoma and Modulates Cell Survival and 3D Growth by Inducing Cellular Senescence	27
The role of the medicinal leech HvRNASET2 enzyme during tissue remodeling	22
The medicinal leech HvRNASET2 enzyme as a promising molecule during tissue regeneration	20
Proline Dehydrogenase affects Lung Cancer cell proliferation by inducing ROS and cellular senescence	17
The Potential Role of the T2 Ribonucleases in TME-Based Cancer Therapy	17
A dual role of Proline Dehydrogenase in Lung Cancer	17
MiR-223-3p in Cancer Development and Cancer Drug Resistance: Same Coin, Different Faces	17
Emerging role of Proline Dehydrogenase in 2D and 3D growth of Lung Cancer cells resistant to Tyrosine Kinase Inhibitors	12
Proline Dehydrogenase as new marker and target in EGFR mutant Non-Small Cell Lung carcinoma	10
Proline Dehydrogenase as a player in acquired resistance to Tyrosine Kinase Inhibitors	9
Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study	5
Totale	9.127

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	33.713
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	33.713

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	1.031	0	0	0	0	94	177	212	178	124	123	25	98
2020/2021	1.331	23	125	40	102	47	161	49	96	186	173	117	212
2021/2022	921	124	129	52	39	38	37	62	70	65	124	68	113
2022/2023	1.244	104	75	88	147	83	268	69	155	131	41	45	38
2023/2024	1.763	283	268	265	299	329	145	20	26	58	8	15	47
2024/2025	511	10	17	223	71	190	0	0	0	0	0	0	0
Totale													9.127